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Xenopus laevisFMR1 and FXR1 are RNA binding proteins interacting with the miRNA-induced silencing complex, RISC. Here
we describe for the ﬁrst time the function of these proteins during eye and neural crest (NC) development in
Xenopus laevis. A loss of FMR1 or FXR1 results in abnormal eye development as well as defects in cranial
cartilage derived from cranial NC cells. We further investigated the possible mechanism of these phenotypes
by showing that a depletion of Dicer, an important enzyme for generating all mature miRNAs, in the anterior
neural tissue also leads to eye and cranial cartilage defects. Furthermore, we examined the function of 12
miRNAs during anterior neural development. We show a speciﬁc requirement of six selected miRNAs during
eye and cranial cartilage development. Mir-130a, -219, and -23b are involved in eye formation only whereas
loss of miR-200b, miR-96 and miR-196a results in strong defects during eye as well as cranial cartilage
development. Our results suggest an essential role for FMR1 and FXR1 for eye and NC development in
X. laevis likely through an interaction with the miRNA pathway.).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
FMR1 (fragile Xmental retardation syndrome 1) and its autosomal
homolog FXR1 (fragile X related 1) form a small gene family. In human
and mouse, a third member of this family, FXR2, has been described
(Penagarikano et al., 2007). It has been shown that all members are
able to form homo- as well as heteromers. A loss of FMR1 protein
caused by an expansion of a CGG trinucleotide sequence in the 5′UTR
sequence of the FMR1 gene results in the most common form of
humanmental retardation, the fragile X mental retardation syndrome
(Pieretti et al., 1991). All three members of this protein family contain
two KH (K protein homology) domains, an RGG box and signals for
nuclear import and export. The KH domain and the RGG box can bind
to G-quartet structures (Darnell et al., 2001; Schaeffer et al., 2001) and
U-rich motifs (Denman, 2003) in RNA molecules. Thereby these
proteins are involved in intracellular RNA transport as well as
translational regulation (Zarnescu et al., 2005). Furthermore, FMR1
and FXR1 can interact with components of the miRNA pathway such
as Dicer or components of RISC (miRNA-induced silencing complex)
(Caudy et al., 2002; Ishizuka et al., 2002; Jin et al., 2004) linking
FMR1/FXR1 to the miRNA machinery.
MicroRNAs (miRNAs) are small single-stranded RNAs with a
length of 22–25 nucleotides. They represent non-protein coding RNA
molecules regulating gene expression on a posttranscriptional levelby binding to the 3′untranslated region (3′UTR) of target mRNAs.
miRNA genes are transcribed by RNA-polymerase II generating
primary transcripts called pri-miRNA. These pri-miRNAs are sequen-
tially processed by two RNase III enzymes, Drosha and Dicer, resulting
in double-stranded miRNA duplexes. These duplexes are separated
into single-stranded miRNA molecules, one of which is degraded and
the other one binds to RISC. This ribonucleoprotein complex binds to
the 3′UTR of target RNAs which can lead to the degradation or
translational regulation of the respective RNA molecule (He and
Hannon, 2004). Many studies indicated that miRNA-mediated gene
regulation has important roles during early embryonic development
(Bushati and Cohen, 2007; Stefani and Slack, 2008). In mice, the
homozygous loss of Dicer leads to lethality early during development
(Bernstein et al., 2003). Dicer mutant zebraﬁsh embryos display
morphogenetic defects during gastrulation, brain formation, somito-
genesis and cardiogenesis (Giraldez et al., 2005) and die after 3 weeks
(Wienholds et al., 2003). Tissue-speciﬁc downregulation of Dicer
resulted in diverse phenotypes. In the retina for example, a loss of
Dicer causes misorganization of photoreceptor cells as well as retinal
degeneration at later stages of development (Decembrini et al., 2008).
Many studies revealed an involvement of miRNAs during neural
development (Hornstein et al., 2005; Choi et al., 2008; Zhang et al.,
2008; Papagiannakopoulos and Kosik, 2009; Peter, 2009; Qiu et al.,
2009; Walker and Harland, 2009).
Here we analyzed for the ﬁrst time the function of FMR1 and FXR1
during early anterior neural development in Xenopus laevis by use of
a morpholino oligonucleotide (MO) based knock down approach.
Downregulation of FMR1 as well as FXR1 led to abnormal eye and
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Dicer and some selected miRNAs in the same tissue suggesting that
FMR1/FXR1 function is essential for early neural development likely
by interacting with the miRNA pathway.
Materials and methods
X. laevis
X. laevis embryos were obtained and staged by standard protocols.
Morpholino oligonucleotides (MO)
MOs were obtained by Gene Tools, LLC, OR and resuspended in
DEPC-H2O. For loss of FMR1 function we injected an MO with the
following sequence: 5′-CTC CTC CAT GTT GGG TCC GCA CGA T-3′. To
test the functionality and binding speciﬁcity of the FMR1 MO we
performed a coupled transcription and translation assay (TNT-Kit)
following the manufacturer's protocol (Promega). For FXR1 knock
down studies, we injected an FXR1 MO as previously published (Huot
et al., 2005). For knocking down Dicer function, we designed twoMOs
with the following sequences: Dicer MO1: 5′-GGC CTG CCA TGC TGA
GGG TCTGCA A-3′; and Dicer MO2: 5′-GAG TCA TGA GCT GAA GGC
CTG CCA T-3′. The sequences of the MOs targeting the formation of or
the matured miRNAs are: miR-130a MO: 5'-AAT GCC CTT TTA ACA
TTG CAC TGC T-3′; miR-219 MO: 5′-CAA GAA TTG CGT TTG GAC AAT
CAA G-3′; miR-23b MO: 5′-GTG GTA ATC CCT GGC AAT GTG ATT T-3′;
miR-200b MO: 5′-AAT CAT CAT TAC CAG GCA GTA TTA G-3′; miR-96
MO: 5′-AAG CAA AAA TGT GCT AGT GCC AAA G-3′; miR-196a MO: 5′-
TCC CAA CAA CAT GAA ACT ACC TAA A-3′; miR-124: 5′-TTG GCA TTC
ACC GCG TGC CTT AATT-3′; miR-98: 5′-ACA ACA ATA CAA CTT ACT
ACC TCA T-3′; miR-24a: 5′-AAC TGA TAT CAG TTC AGT AGG CAC A-3′;
miR-18a: 5′-ACT ATC TGC ACT AGA TGC ACC TTA G-3′; Let-7a: 5′-TCA
ACT ATA CAA CCT ACT ACC TCA G-3′; and Let-7f: 5′-AAA ACT ATA CAA
TCT ACT ACC TCA T-3′. The standard control MO of Gene Tools was
used for control experiments. If not indicated, the injected MO
concentrations are: FMR1: 30 ng, Dicer MO1 and 2: 20 ng; miR-130a
MO: 40 ng; miR-219 MO: 20 ng; miR-23b MO: 30 ng; miR-200b MO:
40 ng; miR-96 MO: 30 ng; and miR-196a MO: 20 ng. For the MOs
targeting miR-124, miR-98, miR-24a, miR-18a, let-7a and let-7f we
used concentrations up to 42 ng. In all experiments, the MOs were
injected unilaterally into one dorso-animal blastomere at 8-cell stage.
GFP-mRNA was used as a tracer. Injection was controlled under a
ﬂuorescence microscope.
Cloning
For all cloning steps proof reading PfuUltra II Fusion HS DNA-
Polymerase (Stratagene) was used. The PCR reactions were done on
cDNA obtained from X. laevis embryos at stage 23 (Dicer probe), stage
27 (FXR1 full length construct) and stage 31 (FMR1 full length
construct). To examine the spatial expression pattern aswell as rescue
experiments, we cloned the full length FMR1 and the Δ5′UTR FMR1
constructs ﬁrst into the pSC-B vector (Stratagene) and then into the
pCS2+ or pDH105 vector using ClaI. The primer sequences based on
the published Xenopus FMR1 sequence (Acc. No. NM_001085587) are:
ClaI5FMR1_l: 5′-CCA TCG ATC GCG AAA CGG GAC CCC GTC CG-3′;
ClaIFMR1_l: 5′-CCA TCG ATA TGG AGG AGC TGG CCG TGG AGG TG-3′;
and ClaIFMR1_R: 5′-CCA TCG ATT TAT GGT ACG CCA TTA ACC AC-3′.
The FXR1 primer sequences for the cloning of the full length and Δ5′
UTR constructs are: 5′UTR_FXR1_l: 5′-CAA TCG ATC TTT TAC CCA TCC
CTT CCT TT-3′; FXR1_l: 5′-CCA TCG ATA TGG AGG ACA TGA CGG TGG
AA-3′; and FXR1_r: 5′-CCA TCG ATT TAA GAC ACC CCA TTC ATT AT-3′.
By cloning and sequencing the full length FMR1 construct we realized
some differences in our sequence in comparison to the published
X. laevis FMR1 sequence (Acc. No. NM_001085587). In the 5′UTRregion at position 122 we observed a nucleotide exchange from G to C
which can also be found in the published X. tropicalis sequence (Acc. No.
NM_001005454). We additionally discovered three exchanges in the
open reading frame resulting in amino acid exchanges: at position 312
from A to T (arginine to serine), at position 976 from A to G (asparagine
to aspartate) and at position 1257 from C to G (histidine to glutamine).
An amino acid alignment comparing our sequence and the published
X. tropicalis (Acc. No. NM_001005454) and Mus musculus (Acc. No.
NM_008031) sequences revealed that our sequence of FMR1 shows
higher similarities to these orthologues than the published X. laevis
sequence. The XenopusDicer sequence has been depositedwith the Acc.
No. XL414a12ex in the Gurdon Institute X. laevis EST database and can
be found at http://www.xenbase.org/gene/showgene.do?method=
displayGeneSummary&geneId=491113. To investigate the spatio-
temporal expression pattern of Dicer, we cloned a Dicer fragment
receivedbyaPCRwith a lengthof 497 bp intopSC-Bvector (Stratagene).
Primer sequences are: Dicer_probe_l: 5′-TTG CAG ACC CTCAGC ATG G-
3′; and Dicer_probe_r: 5′-AGA TTA ATG TTT GACAATGAC AC-3′. To test
the binding speciﬁcity of the Dicer MOs used, we cloned upon touch-
down PCR theDicerMObinding site in front to and in framewith GFP in
pCS2+ by using following primers: Dicer_MO_l: 5′-GAT CCT TGC AGA
CCC TCA GCA TGG CAG GCC TTC AGC TCA TGA CTC CG-3′; and
Dicer_MO_r: 5′-AAT TCGGAG TCA TGAGCTGAAGGCCTGCCA TGC TGA
GGG TCT GCA AG-3′. The primers contained sticky ends for BamH1 and
EcoR1 and 5′ ends were phosphorylated.
Whole mount in-situ hybridizations (WMISH)
Wildtype or MO injected embryos were ﬁxed at indicated stages
with MEMFA (0.1 M MOPS (pH 7.4), 2 mM EGTA, 1 mM MgSO4, and
4% formaldehyde) over night at 4 °C. WMISH was done according to
standard protocols (Hemmati-Brivanlou et al., 1990). After staining,
the embryos were reﬁxed in MEMFA and bleached in 30% H2O2 for
several hours. For sections, the embryos were embedded in gelatine/
BSA and cut with a thickness of 20–30 μm.
Alcian blue staining
For Alcian blue staining, the cranial cartilage was dissected after
removing the skin ofﬁxedXenopus embryos at stage 46. The subsequent
staining was done as previously described (Gessert et al., 2007).
Cartilage photos were placed in front of a homogenous background.
Results
FMR 1 and FXR1 function in the developing eye and NC cells
We ﬁrst analyzed the spatial expression of FMR1 and FXR1 during
X. laevis embryogenesis thereby completing earlier studies by others.
At late embryogenesis, FMR1 is expressed in the neural tube, the eyes,
the otic vesicles and the pharyngeal arches (Lim et al., 2005). We
could detect FMR1 transcripts in anterior neural tissue at stage 15, and
later in the eye anlage, migrating NC cells, the otic vesicle and the
pronephric nephrostomes (Suppl. Fig. 1A). FXR1 protein could be
mainly detected in the developing somites of tailbud stage embryos
(Huot et al., 2005). In addition we found FXR1 to be also expressed in
anterior neural tissue. A weak staining in the eye can also be detected
at stage 28 (Suppl. Fig. 1B).
We next investigated the function of FMR1 and FXR1 performing
loss of function experiments using speciﬁc antisense MOs. The FMR1
MO was designed to cover the AUG start codon. In an in vitro
transcription and translation assay, we could show that the FMR1 MO
used speciﬁcally blocks the translation of FMR1 RNA including the 5′
UTR (5′UTR FMR1 construct, Suppl. Fig. 2). Furthermore the FMR1MO
is unable to inhibit translation of an FMR1 construct lacking the 5′UTR
and thus lacking most part of the MO binding site (Δ5′UTR FMR1
Fig. 1. Downregulation of FMR1 results in defects during eye as well as cranial cartilage development. A. Injection of FMR1 MO led to abnormal eye development (white and black
arrows) in a dose-dependent manner as judged by the RPE. Control MO injection did not interfere with eye development. Vibratome sections showed disorganized layers of the
retina as well as missing ventral RPE (black arrowheads). The coinjection of FMR1 MO with Δ5′UTR FMR1 or Δ5′UTR FXR1 RNA resulted in a rescue of the eye phenotype, see also
Suppl. Fig. 4. B. Downregulation of FMR1 function resulted in reduced cranial cartilage structures on the injected side (arrows) shown by Alcian blue staining. Control MO did not
interfere with cartilage development. Quantitative presentations are given. Abbreviations: ac = auditory cap; apc = anterior parachordal cartilage; ba = branchial arches; ic =
infrarostral cartilage; mc = Meckels cartilage; n = number of independent experiments; N = number of analyzed embryos; ng = nanogram; ta = tectum anterius.
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subsequent rescue approaches.
In all experiments we injected the FMR1 MO unilaterally into one
animal-dorsal blastomere of 8-cell stage embryos. Fate mapping
studies had shown that this blastomere is contributing to anterior
neural tissue, including the eye, brain and NC cells (Moody, 1987). In
all experiments coinjection of GFP RNA served as an injection control.
GFP expressionwasmonitored at stage 13 or 23. Embryos negative for
GFP in anterior neural tissue were not further considered.
In a ﬁrst set of experiments we injected 20, 25 and 30 ng of the
FMR1 MO. Loss of FMR1 function resulted in an eye phenotype in-
cluding smaller, abnormal and absent eyes as judged by the size of the
retinal pigment epithelium (RPE) (Fig. 1A). The individual layers of
the retina were not distinguishable and the ventral RPE was missing
giving rise to a coloboma. The same phenotype was observed after
injecting a previously characterized FXR1 MO (Suppl. Fig. 3). Control
MO injection had no inﬂuence on eye development. This eye phe-
notype could be partially reverted by coinjection of Δ5′UTR FMR1 andFig. 2. FMR1 interferes with late eye and NC cell development. A. Injection of FMR1 and Co
B. FMR1 deﬁcient embryos showed a reduced expression of eye marker genes Rx1 and P
C. Inhibition of FMR1 resulted in defects in NC cell migration at stage 20 (FoxD3 expression, a
the difference of migrating Krox20-positive NC cells between uninjected and FMR1 MO
experiments; N = number of analyzed embryos.Δ5′UTR FXR1 RNA which are both not targeted by the FMR1 MO
(Fig. 1A and Suppl. Fig. 4). This indicates that the observed eye
phenotype is speciﬁc and that FMR1 and FXR1 are at least partially
functionally redundant. Since FMR1 is expressed in migrating NC cells
we also investigated the development of cranial cartilage as one
derivative of the NC cells and analyzed this structure by Alcian blue
staining. Downregulation of FMR1 resulted in reduced and deformed
cranial cartilage structures on the injected side in a dose-dependent
manner (Fig. 1B). Similar, the downregulation of FXR1 resulted in a
cranial cartilage phenotype (Suppl. Fig. 3).
Next, we investigated the molecular basis of the defects in eye and
cranial cartilage structures upon FMR1 inhibition. For all following
experimentswe injected 30 ng of the FMR1MO. The injection of FMR1
MO did not inﬂuence the induction of neural tissue shown by the
expression of the pan-neural marker gene Sox3 and the early eye
marker genes Rx1 and Pax6 (Fig. 2A). Also the induction of NC cells
was unaffected as indicated by the expression of FoxD3 and Slug at
stage 17 (Fig. 2A). Later, however, loss of FMR1 function resulted in antrol MO had no effect on the expression of neural marker genes at stages 13 and 17.
ax6 on the injected side (arrows) at stage 23. A quantitative representation is given.
rrow) and stage 23 (expression of Krox20 and Twist, arrows). The red brackets highlight
injected sides. A quantitative presentation is shown. n = number of independent
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226 S. Gessert et al. / Developmental Biology 341 (2010) 222–235smaller expression domain of Rx1 and Pax6 (Fig. 2B). At stage 20
cranial NC cells start to migrate from the dorsal side of the neural tube
contributing to structures such as cranial nerves and cartilage.
Therefore we analyzed whether FMR1 depletion leads to defects in
NC cell migration by investigating the expression of FoxD3 at stage 20
and Krox20 as well as Twist at stage 23. The injection of FMR1 MO
resulted in a severe migration defect as indicated by all three marker
genes analyzed (Fig. 2C). In additionwe investigated the expression of
brain marker genes Emx1 (forebrain), En2 (isthmus), and Krox20
(rhombomeres 3 and 5 of the hindbrain). Loss of FMR1 function did
not interfere with the expression of these genes in the brain (Suppl.
Fig. 5) indicating the speciﬁcity of the observed effects.
In summary, these data suggest that FMR1 is neither required for
neural induction in general nor for induction of the eye anlage or NC in
particular. In contrast, FMR1 is essential for further development of
the eye and for migration of NC cells.
Loss of Dicer phenocopies the effect of FMR1 downregulation in the eye
and NC cells
FMR1 and FXR1 have been shown to interact with RISC and RNA
molecules and to regulate RNA stability, transport and localization in
neurons (Jin et al., 2004; Zarnescu et al., 2005). As the observed
phenotype was accompanied by changes in gene expression on the
RNA level, we hypothesized that FMR1 and FXR1 function through
miRNAs in this context. If a loss of FMR1/FXR1 results in deﬁcits of
miRNA function, then a general loss of miRNA production should
result in the same or a similar phenotype. We therefore focused ourFig. 3. Loss of Dicer function leads to eye and cartilage malformations. A. Dicer deﬁcient emb
Injection of 20 ng Control MO had no effect on eye development. A quantitative presentation
structures on the injected side (black arrows). Control MO injection did not inﬂuence cartil
apc = anterior parachordal cartilage; ba = branchial arches; ic = infrarostral cartilage; mc=
embryos; ng = nanogram; ta = tectum anterius.further attempts on the functional characterization of Dicer in anterior
neural tissue.
We ﬁrst analyzed the spatial expression pattern of Dicer. Dicer is
ubiquitously expressed with an accumulation of Dicer transcripts in
the anterior neural tissue during early X. laevis development (Suppl.
Fig. 6). For the functional analyses of Dicer we designed two antisense
MOs (Dicer MO1 and MO2) for knock down experiments. First we
tested the functionality of the designed MOs by cloning the MO
binding sites in front of and in frame with GFP. RNA of these con-
structs was injected together with the respective MO into early
Xenopus embryos. Both Dicer MOs but not a Control MO blocked the
translation of the GFP reporter (Suppl. Fig. 7).
To examine the function of Dicer during anterior neural develop-
ment, we injected both Dicer MOs independently into one animal-
dorsal blastomere of 8-cell stage embryos. Upon Dicer downregula-
tion, we observed strong defects in eye as well as cranial cartilage
development at stages 42 and 46 in a concentration dependent
manner (Fig. 3). In case of the eye, the injection of Dicer MO1 as well
as MO2 led to smaller, abnormal and absent eyes as determined by
morphology of the embryos (Fig. 3A) as well as transversal sections
(data not shown). The injection of a Control MO had no effect on eye
development. Due to the large size of the Dicer transcript (5.7 kb)
rescue experiments could not be performed. We considered this
phenotype nevertheless to be speciﬁc as two independent MOs
resulted in the same outcome. All further experiments were per-
formed with 20 ng of MO. To analyze cartilage structures after Dicer
MO injections, we isolated the cranial cartilage at stage 46 and
performed an Alcian blue staining. After Control MO injection allryos showed defects in eye development (white arrows) in a dose-dependent manner.
is given. B. Injection of 20 ng Dicer MO1 or MO2 resulted in abnormal cranial cartilage
age development. A quantitative evaluation is given. Abbreviations: ac = auditory cap;
Meckels cartilage; n=number of independent experiments; N=number of analyzed
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Dicer resulted in a strong deformation of cranial cartilage on the
injected side (Fig. 3B).
We next aimed to analyze these two phenotypes in more detail. A
similar eye phenotype after Dicer depletion was also reported earlier
by others (Decembrini et al., 2008), however, a molecular analysis at
different stages of development, in particular earlier stages, was not
performed. In a ﬁrst step we therefore investigated the effect of Dicer
knock down on the expression of early eye marker genes such as Rx1
and Pax6 and the pan-neural marker gene Sox3 at stage 13 (Fig. 4A).
Neither the expression of eyemarker genes nor the expression of Sox3
was affected after loss of Dicer function. NC induction was also not
affected as indicated by the expression of FoxD3 and Slug (Fig. 4A).
We next analyzed the expression of eye marker genes at stage 23
(Fig. 4B) and observed a reduction of Pax6 and Rx1 expression upon
Dicer depletion. We also analyzed the expression of brain-speciﬁc
marker genes such as Emx1, En2 and Krox20. In case of Emx1 and En2,
we observed a slight decrease in only some embryos whereas Krox20
expression in the brain was not affected (Suppl. Fig. 8). The injection
of a Control MO had no effect. A stage 20, inhibition of Dicer resulted
in defects in the migration of NC cells as indicated by FoxD3
expression. This was further conﬁrmed by an altered expression of
Krox20 and Twist at stage 23 (Fig. 4C and Suppl. Fig. 9).
Taken together these data indicate that Dicer is required for the
maintenance of eyemarker genes, for themigration of NC cells and for
the development of eye and crainal cartilage structures in X. laevis.
Furthermore, the phenotypes observed after knocking down FMR1/
FXR1 and Dicer are remarkably similar.
miRNAs in Xenopus anterior neural development
We next analyzed the function of particular miRNAs during
anterior neural development. Watanabe et al. (2005) investigated
the temporal expression of some miRNAs during X. laevis develop-
ment and in a recent report, the spatial expression pattern of some
miRNAs during X. tropicalis development was described (Walker and
Harland, 2008). Out of this set of miRNAs we chose miRNAs which
show a speciﬁc expression pattern in anterior neural tissue: miR-219,
-130a, -124, -98, -96, -24a, -23b, -18a and Let7a. Additionally, we
selected miR-200b (Burk et al., 2008), miR-196a (Hornstein et al.,
2005; Qiu et al., 2009) and Let-7f (Wulczyn et al., 2007) as these
miRNAs were linked to epithelial–mesenchymal transition (EMT),
sonic hedgehog (shh) signaling or neural development in general. The
function of miRNAs can be blocked by generating antisense morpho-
lino oligonucleotides covering the maturemiRNAs as well as the Dicer
cleavage site (Martello et al., 2007; Yin et al., 2008; Rosa et al., 2009;
Walker and Harland, 2009). Accordingly, we designed MOs against all
selected miRNAs.
In total, we tested 12miRNAMOs in different concentrations. For a
ﬁrst screening, we analyzed the eye and cartilage development as well
as the expression of Rx1, Pax6 and Twist at stage 23. In case of sixMOs,
we did not observe any phenotype in any of the investigated contexts
(miR-124, -24a, -98, -18a, Let7a and Let7f). This could be due to
several reasons. First, it might well be that the analyzed miRNAs are
not required for the analyzed morphological or molecular features. A
more detailed analysis on a cellular level or using other marker genes
might solve this issue. Second, it might be that the morpholinos are
not functional due to structural problems. For the 6 other microRNAs,
defects in eye and/or NC development were observed and we
completed the marker gene studies similar to those for the FMR1
and Dicer phenotypes, analyzing Rx1, Pax6 and Sox3 at stage 13, Slug
at stage 17, FoxD3 at stage 17 and 20 as well as Emx1, En2 and Krox20
at stage 23. Based on the phenotypes, we classiﬁed the different
miRNAs examined in two functional groups. Three of these miRNAs
(miR-130a, -219 and -23b) showed a phenotype only during eye
development (group one) whereas three other miRNAs (miR-200b,-96, and -196a) revealed an eye as well as cranial cartilage phenotype
(group two).
Phenotypes upon knocking down miR-130a, miR-219 and miR-23b
MiR-130a is expressed in anterior neural tissues like the brain, the
eyes and the branchial arches (Walker and Harland, 2008). Down-
regulation of miR-130a led to smaller eyes (Fig. 5A). On a molecular
level, the injection of miR-130a MO resulted in a reduced expression
of the eye speciﬁc marker genes Rx1 and Pax6 already at stage 13
(Fig. 5B). The pan-neural marker Sox-3, however, was not affected at
this stage. At stage 23 miR-130a depleted embryos showed a decrease
in the expression of Rx1 and Pax6, whereas Emx1, En2 and Krox20
were not affected (Fig. 5C).
During X. tropicalis development, miR-219 is expressed in anterior
neural tissue at stage 19. At stage 30, miR-219 could be visualized in
the brain and the eye (Walker and Harland, 2008). For miRNA-219 we
observed an eye phenotype upon MO injection in a dose-dependent
manner (Fig. 5D). Loss of miR-219 led to smaller eyes without any
apparent changes in the different layers of the retina. At stage 13, miR-
219 knock down resulted in a slight decrease of Rx1 and Pax6
(Fig. 5E). Sox3 was not affected at this stage. The effect on Rx1 and
Pax6 expression was stronger at stage 23 (Fig. 5F). The expression of
brain marker genes Emx1, En2, and Krox20, however, was unchanged
after miR-219 MO injection.
MiR-23b is speciﬁcally expressed in the hindbrain and the eye of
X. tropicalis (Walker and Harland, 2008). Injecting miR-23b MO
resulted in abnormalities during eye development (Fig. 5G). Histo-
logical sections reveal a misorganization of the RPE as well as the
layers of the retina. Fig. 5H shows that the injection of 30 ng miR-23b
MO has only a slight effect on early eye marker gene expression. At
stage 23, Rx1 and Pax6 were strongly reduced in miR-23b deﬁcient
embryos (Fig. 5I). The analyzed brain markers were only slightly
affected after miR-23b depletion.
Phenotypes upon knocking down miR-200b, miR-96 and miR-196a
Recently published reports allocated different members of the
miR-200 family as important regulators in EMT (Peter, 2009) which
plays also an important role during NC cell development. In a ﬁrst set
of miR-200b knock down experiments, we observed abnormal or
absent eyes (Fig. 6A). The induction of the eye ﬁeld, however, was
unaffected (Fig. 6B). At later stages, loss of miR-200b led to a
reduction in Rx1 and Pax6 (Fig. 6C). Emx1 and En2 were only faintly
affected. Additionally, miR-200b depletion resulted in abnormal
cranial cartilage structures (Fig. 6D). Surprisingly, the induction as
well as the migration of NC cells was not disturbed as indicated by the
expression of speciﬁc NC marker genes (Figs. 6E and F).
Walker and Harland (2008) indicated that the expression of miR-
96 is correlated with anterior neural tissue in X. tropicalis and that this
miRNA is speciﬁcally expressed in the brain, the eyes and the
branchial arches at stage 30. In our functional approaches we
observed defects in eye as well as cranial cartilage development
after inhibition of miR-96 (Figs. 7A and D). At stage 13, the pan-neural
marker gene Sox3 was unaffected, but the induction of the eye ﬁeld
was impaired in some of the embryos (Fig. 7B). The reduction of Rx1
and Pax6 was more prominent during later development (Fig. 7C). At
stage 23, the expression domain of En2 was slightly expanded in
around 27% of the embryos. In addition, the induction of NC cells
indicated by the expression of Slug and FoxD3 at stage 17was affected
by the depletion of miR-96 (Fig. 7E). At later stages we could also
observe a downregulation of FoxD3 (stage 20) as well as Krox20 and
Twist (stage 23) (Fig. 7F).
Qiu et al. (2009) recently demonstrated that the overexpression of
miR-196a induces eye defects in X. laevis. MiR-196a was also im-
plicated in shh signaling (Hornstein et al., 2005) which is also
Fig. 4.Dicer function on amolecular level. A. The injection of 20 ng DicerMO1 had no effect on Rx1, Pax6 and Sox3 at stage 13 as well as FoxD3 and Slug at stage 17. B. At stage 23, loss
of Dicer function by injecting Dicer MO1 and MO2 led to the reduction of eye marker gene expression (black arrows). Control MO injected embryos showed a normal expression
pattern. A quantitative presentation is given. C. The migration of NC cells was disturbed upon Dicer MO1 and MO2 injection (black arrows). FoxD3 at stage 20 and Krox20 and Twist
at stage 23were reduced upon loss of Dicer function (black arrows). Control MO injected embryos served as control. A quantitative presentation is given. n=number of independent
experiments; N = number of analyzed embryos.
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Fig. 5. Phenotype of miR-130a, miR-219 and miR-23b MO injections. A. Injection of miR-130a MO resulted in smaller eyes on the injected side (white and black arrows) in a dose-
dependent manner. Histological sections showed that the different layers of the retina were not disturbed (black arrow). Control MO injection did not affect eye development. B. Loss
of miR-130a function did not alter the expression of the pan-neural marker gene Sox3 at stage 13, but the expression of Rx1 and Pax6 (back arrows). C. MiR-130a MO injected
embryos revealed a downregulation of Rx1 and Pax6 at stage 23 (black arrows), but no chance in the expression of brainmarker genes. D. MiR-219 deﬁcient embryos showed smaller
eyes (white and black arrows) in contrast to the control embryos (Control MO). E. The injection of 20 ngmiR-219MO led to a reduced expression of Rx1 and Pax6 (black arrows), but
not of Sox3 at stage 13. F. The expression of Rx1 and Pax6 (black arrows) at stage 23 was downregulated upon loss of miR-219, whereas Emx1, En2 and Krox20 were not affected.
G. The injection of miR-23b MO resulted in the development of abnormal eyes which are completely deformed (white arrows). In many embryos, the RPE was not closed at the
ventral side of the embryo (right panel). The quantitative representation shows that this effect was dose-dependent. H. Expression of Rx1, Pax6 and Sox3 at stage 13. Loss of miR-23b
led to a slight reduction in Rx1 and Pax6 expression. Sox3 was not affected. I. MiR-23b deﬁcient embryos showed a strong downregulation of Rx1 and Pax6 and a slight reduction of
Emx1, En2 and Krox20 on the injected side at stage 23 (black arrows). For all experiments a quantitative representation is shown. n= number of independent experiments; N =
number of analyzed embryos.
229S. Gessert et al. / Developmental Biology 341 (2010) 222–235required for splitting the early eye ﬁeld into two lateral domains. We
here addressed the question whether the downregulation of this
miRNA has an effect on anterior neural development. The depletion of
miR-196a led to a strong eye phenotype (Fig. 8A). Histological sec-
tions of the embryos clearly present that the different eye structures
including the different layers of the retina and the lens are completely
disorganized. By investigating the role for miR-196a on a molecularlevel, we realized that neural induction was normal as indicated by
the expression of Sox3 at stage 13 (Fig. 8B). At this stage of
development, Rx1 and Pax6 were only slightly downregulated.
Fig. 8C reveals that the knock down of miR-196a results in a diffused
and expanded expression pattern of all examined neural marker
genes Rx1, Pax6, Emx1, En2 and Krox20 in contrast to the expression
pattern in Control MO injected embryos. Furthermore, miR-196a MO
Fig. 6.miR-200b MO phenotype. A. The injection of miR-200b MO led to abnormal eye structures or even absent eyes on the injected side (white arrows). Histological sections conﬁrmed this observation. A quantitative representation depicts
the dose-dependency of this MO effect. B. The expression of Rx1, Pax6 and Sox3 was not affected upon injection of 40 ng miR-200b MO. C. At stage 23, Rx1 and Pax6 expression are downregulated after loss of miR-200b (black arrows). Other
examined brain markers were not affected. D. Alcian blue staining at stage 46. MiR-200b deﬁcient embryos showed smaller cranial cartilage structures on the injected side (black arrows). A quantitative representation is given. E. Slug and
FoxD3 expression at stage 17 was not affected upon miR-200b depletion. F. The injection of 40 ng miR-200b MO had no effect on the expression of FoxD3 at stage 20 and Krox20 and Twist at stage 23. A quantitative representation is shown.
n = number of independent experiments; N = number of analyzed embryos.
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Fig. 7.miR-96 MO phenotype. A. Loss of miR-96 function was accompanied by eye malformations (white arrows). B. Injection of 20 ng miR-96 MO resulted in a slight downregulation of Rx1 and Pax6 on the injected side at stage 13 (black
arrows). C. At stage 23, depletion of miR-96 led to a strong downregulation of Rx1 and Pax6 on the injected side (black arrows). Emx1 and Krox20 were not affected, whereas the expression domain of En2 was broadened in around 27% of the
analyzed embryos (black arrow). D. The downregulation of miR-96 was followed by a reduction of the cranial cartilage on the MO-injected side of the embryo (black arrows). The cartilage preparation of the control MO injected embryo is
identical to Fig. 6D. E. At stage 17, the expression of Slug and FoxD3 was disturbed after loss of miR-96 function (black arrows). E. At stage 20, FoxD3 expression was downregulated on the injected side. At stage 23, Krox20 and Twist were
reduced after the injection of 20 ng miR-96 MO (black arrows). For all shown experiments, quantitative representations are given. n = number of independent experiments; N = number of analyzed embryos.
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Fig. 8.miR-196a MO phenotype. A. The injection of miR-196a MO led to a strong eye phenotype on the injected side in a dose-dependent manner (black and white arrows). B. The early eye marker genes Rx1 and Pax6 were slightly affected
upon loss of miR-196a function. C. The injection of 20 ng miR-196a MO resulted in a diffused and broadened expression pattern of Rx1, Pax6, Emx1, En2 and Krox20 at stage 23. D. Loss of miR-196a led to reduced cranial cartilage at stage 46
(black arrows). E. At stage 17, the expression of Slug and FoxD3 was strongly affected upon miR-196a depletion. E. FoxD3 at stage 20 and Krox20 and Twist at stage 23 were downregulated after injection of 20 ng miR-196a MO. For all shown
experiments, quantitative representations are given. n = number of independent experiments; N = number of analyzed embryos.
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233S. Gessert et al. / Developmental Biology 341 (2010) 222–235injection led to smaller cartilage on the injected side (Fig. 8D). By
looking on molecular marker genes important for NC cell develop-
ment, we observed an inhibition of Slug (stage 17), FoxD3 (stages 17
and 20), Krox20 and Twist (stage 23) (Figs. 8E and F).
In summary, half of the analyzed miRNA MOs resulted in a
phenotype in anterior neural tissue affecting brain, eye and/or
cartilage development. In contrast to the observed FMR1/FXR1 and
Dicer knock down phenotypes, the downregulation of some miRNAs
additionally led to earlier defects already during eye ﬁeld and NC
induction. Similar to the results of FMR1/FXR1 and Dicer MO
injections, the loss of some miRNA functions resulted in eye and
cranial cartilage abnormalities. These data are in line with the idea
that the FMR1/FXR1 loss of function phenotype might be due to
defects in the miRNA pathway.
Discussion
FMR1 and FXR1 function in eye and cranial cartilage development
Here we show for the ﬁrst time a requirement for FMR1/FXR1
during eye and cranial cartilage development in X. laevis as
determined by knock down experiments. Analyses on a molecular
level indicated that FMR1 is not required for neural induction in
general including establishment of the early eye ﬁeld and formation of
NC cells. Later during development, however, changes in gene
expression as well as in eye morphogenesis and NC cell migration
could be observed. It should be noted that our data do not exclude an
earlier function of FMR1/FXR1 as maternal protein stores of these
proteins are not affected by MO based knock down approaches. How
do these phenotypes in Xenopus relate to those observed in mouse
models?
FXR1 knock out mice have been generated (Mientjes et al., 2004)
but die early during embryogenesis. The molecular basis of this
lethality has not been completely investigated. Loss of function
analyses in X. laevis, however, already indicated deﬁcits in somitogen-
esis, which is in agreement with the major expression domain of
FXR1. Microarray gene expression analyses have been performed in
Xenopus and implied numerous neural genes to be affected in FXR1
knock down embryos including signaling molecules and transcription
factors required for early embryonic and neural development (Huot
et al., 2005).
An FMR1 knock out mouse has also been generated without any
gross morphological defects. This difference in phenotypes (Xenopus
versus mouse) might be explained by functional redundancies
between different members of the FMR1 gene family. Whereas in
mammals three members of the family were described, only FMR1
and FXR1 are present in Xenopus (Blonden et al., 2005). Of note, FMR1
KO stem cells display defects in neural differentiation (Castren et al.,
2005). Also in zebraﬁsh, morpholino mediated knock down of FMR1
resulted in craniofacial cartilage defects (Tucker et al., 2006), although
this has recently been challenged by the generation of FMR1 mutant
ﬁsh (den Broeder et al., 2009). In Drosophila, only one member of the
family, dFMR, exists. dFMR has been shown to be involved in proper
eye development (Wan et al., 2000). Furthermore, as in case of FXR1,
RNA binding partners for FMR1 have been identiﬁed and thus might
reﬂect transcripts that are potentially regulated by FMR1 (Sung et al.,
2000; Darnell et al., 2001; Denman, 2003) including genes involved in
regulating cellular differentiation or cell migration.
Molecular basis of the FMR1/FXR1 phenotype
Previous publications linked FMR1/FXR1 to themiRNAmachinery.
We therefore analyzed the potential involvement of miRNAs in the
observed FMR1/FXR1 phenotype by investigating the function of
Dicer, which is required for the generation of all mature miRNAs. We
here demonstrated for the ﬁrst time that a neural-speciﬁc loss of Dicerfunction leads to eye as well as cranial cartilage defects during
Xenopus development by the injection of two independent MOs. In
mice and zebraﬁsh, Dicer knock out embryos die very early in
development (Bernstein et al., 2003; Wienholds et al., 2003) showing
the importance of this gene and miRNAs for early steps of vertebrate
development. Most likely, this early requirement for Dicer is obscured
in Xenopus due to the maternal stores of Dicer protein (Fruscoloni
et al., 2003). Two recently published studies in mouse and Xenopus
also showed defects during late eye development when the function
of Dicer was depleted speciﬁcally in retina cells (Damiani et al., 2008;
Decembrini et al., 2008). Since nothing is known about the molecular
basis of the eye phenotype, we analyzed the induction of the neural
plate and the eye ﬁeld at stage 13 and did not observe any defects.
Later in Xenopus development, however, eye marker genes are
reduced in Dicer deﬁcient embryos. During zebraﬁsh development,
Dicer possesses a function in themorphogenesis of the brain (Giraldez
et al., 2005) without major defects in gene expression. This is in
agreement with our observation of unaltered brain-speciﬁc marker
gene expression in early Xenopus development.
In addition to the eye phenotype we observed a cranial cartilage
phenotype upon Dicer downregulation. Dicer has been shown to be
essential for skeletal development in mice due to a decreased
proliferation rate and abnormal differentiation of chondrocytes
(Kobayashi et al., 2008). The development of the cranial cartilage in
Xenopus requires the migration of NC cells from the dorsal neural
tube. We here show that NC cells were correctly induced but
migration was impaired upon Dicer knock down pointing towards a
function of Dicer in regulating cellular behavior.
When comparing the phenotypes of FMR1/FXR1 and Dicer it
becomes evident that they are very similar: no deﬁcits in early neural
induction and speciﬁcation steps. Later, however, both knock downs
are characterized by defects in eyemorphology including altered gene
expression and an altered migration behavior of NC cells. Our ﬁndings
are therefore in good agreement with previous ﬁndings indicating
FMR1/FXR1 to be involved in regulating mRNA stability and mRNA
translation through interaction with RISC and the miRNA pathway.
Downregulation of miRNAs during Xenopus development
It can be assumed that the observed phenotypes upon FMR1/FXR1
depletion are due to the function of some speciﬁc miRNA molecules.
We therefore interfered with the function of 12 selected miRNAs by
use of MOs as previously done for other miRNAs (Martello et al., 2007;
Yin et al., 2008; Rosa et al., 2009; Walker and Harland, 2009). The
injection of six miRNA MOs resulted in a phenotype in eye or cranial
cartilage development. Three of the miRNAs only showed abnormal
eyes (miR-130a, -219 and -23b) whereas the other three are involved
in eye as well as cranial cartilage development (miR-200b, -96 and
-196a).
Someof thesemiRNAsdeserve amore detailed discussion.Depletion
of miR-200b results in strong eye defects such as misorganized or
missing eyes and reduced cartilage structures. Recently, several studies
suggested a role for members of themiR-200 family in EMT (Burk et al.,
2008; Korpal and Kang, 2008; Korpal et al., 2008; Paterson et al., 2008).
We could not observe, however, any defects in NCmigration suggesting
no disturbance in EMTby loss ofmiR-200b. Themolecular effect ofmiR-
200b during development of NC thus remains unclear. Earlier studies
suggested a functionofmiR-96 ineyedevelopment (Loscher et al., 2007;
Xu et al., 2007; Loscher et al., 2008; Lewis et al., 2009; Mencia et al.,
2009; Soukup, 2009). By in vitro assays and target prediction, Xu et al.
(2007) showed that the transcription factor Mitf (microphthalmia-
associated transcription factor) is a direct target ofmiR-96.A loss ofMITF
affects developmentof the eye andNC-derivedmelanocytes (Nakayama
et al., 1998; Kumasaka et al., 2005). The misregulation of Mitf through
miR-96 might thus well contribute to the phenotype observed here. In
mouse, zebraﬁsh and Xenopus, miR-196a is expressed in the posterior
234 S. Gessert et al. / Developmental Biology 341 (2010) 222–235trunkduring later development (Mansﬁeld et al., 2004;Wienholds et al.,
2005; Qiu et al., 2009). The expression of miR-196a in early
development is not described yet. In our experiments, the depletion of
miR-196a resulted in malformed eyes and reduced cartilage. Moreover,
marker genes for eye, brain as well as NC cells are affected. In chicken,
miR-196a is regulating Hox genes as well as shh during limp
development (Hornstein et al., 2005). Shh is also involved in eye,
cranial cartilage and neural tube development (Chiang et al., 1996;
Zhang and Yang, 2001). Thus, the observed phenotype could be due to a
misregulation of shh signaling.
In all cases analyzed, loss of miRNA function could well contribute
to the observed FMR1/FXR1 phenotype. It should be mentioned that
the FMR1/FXR1 or Dicer phenotypemight bemore complex than here
described and that other miRNA will surely contribute to this more
complex phenotype. Moreover, it should be noted that a more causal
link cannot be established by experimental means. If FMR1/FXR1
interact with RISC, a loss of FMR1/FXR1 cannot simply be rescued by
providing an excess of the miRNA of interest.
In our analysis we recognized some differences between the
FMR1/FXR1 and Dicer knock down phenotypes on the one side and
themiRNA knock down phenotypes on the other side. For FMR1/FXR1
and Dicer downregulation we only observed a late phenotype starting
around stage 20. In contrast the depletion of some miRNAs also
interfered with the induction of early eye (stage 13) and NC marker
genes (stage 17). We think that Dicer is also essential for early
development including neural induction in Xenopus like in other
organisms (Bernstein et al., 2003; Wienholds et al., 2003) but because
of huge maternal storage of Dicer protein, we do not interfere with
Dicer function early in development. Later, however, the Dicer MO
mediated loss of Dicer protein resulted in abnormal eye and cartilage
development. The maternal storage of Dicer proteins allows further-
more the generation of mature miRNAs during early embryogenesis.
By the injection of miRNA MOs we interfere with their regulation of
target mRNAs. Thereby the function of miRNAs is also depleted in
early development leading to an early effect upon downregulation of
some miRNAs.
Taken together, our here described data argue that FMR1/FXR1 are
important for early eye and NC development likely due to a function in
RISC and the miRNA machinery. The described miRNA phenotypes
provide a good starting point towards a more detailed analysis of the
observed phenotypes.
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